Advertisement

The Use of Anagrelide in Myeloproliferative Neoplasms, With Focus on Essential Thrombocythemia

Results of a recent study indicate that a combination of anagrelide with hydroxycarbamide or interferon is feasible and effective in patients with myeloproliferative neoplasms who have insufficient platelet response to monotherapy.

 Current Hematologic Malignancy Report

click me